Profile data is unavailable for this security.
About the company
Aptose Biosciences Inc. is a clinical-stage biotechnology company engaged in developing precision medicines addressing unmet medical needs in oncology, with an initial focus on hematology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. Its lead clinical-stage compound Tuspetinib (TUS), is an oral kinase inhibitor that has demonstrated activity as a monotherapy and in combination therapy in patients with relapsed or refractory acute myeloid leukemia (AML) and is being developed as a frontline triplet therapy in newly diagnosed AML. Its Luxeptinib (LUX) is being developed for the treatment of patients with certain B-cell malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and certain non-Hodgkin’s lymphomas (NHL) who are resistant or intolerant to conventional treatments.
- Revenue in USD (TTM)0.00
- Net income in USD-40.29m
- Incorporated2006
- Employees35.00
- LocationAptose Biosciences Inc251 Consumers Rd Suite 1105NORTH YORK M2J 4R3CanadaCAN
- Phone+1 (647) 479-9828
- Fax+1 (416) 798-2200
- Websitehttps://aptose.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GT Biopharma Inc | 0.00 | -11.35m | 4.67m | 2.00 | -- | 0.848 | -- | -- | -7.72 | -7.72 | 0.00 | 2.47 | 0.00 | -- | -- | 0.00 | -82.84 | -205.36 | -120.73 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 63.62 | -- | -- | -- |
Silo Pharma Inc | 72.12k | -3.45m | 4.75m | 3.00 | -- | 0.662 | -- | 65.91 | -1.16 | -1.18 | 0.0242 | 1.60 | 0.0079 | -- | -- | 24,040.00 | -37.69 | -24.90 | -43.50 | -26.39 | 91.90 | 82.79 | -4,777.02 | -2,757.85 | -- | -- | 0.00 | -- | 0.00 | -- | 7.07 | -- | -- | -- |
Titan Pharmaceuticals Inc | 4.00k | -5.46m | 4.81m | 4.00 | -- | 1.20 | -- | 1,202.22 | -6.59 | -6.59 | 0.0049 | 4.37 | 0.0016 | -- | 0.1702 | 1,000.00 | -211.58 | -96.80 | -368.99 | -156.65 | -- | -- | -136,525.00 | -406.26 | -- | -309.96 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
AgriFORCE Growing Systems Ltd | 57.60k | -15.05m | 4.90m | 7.00 | -- | 0.3866 | -- | 85.01 | -5.81 | -5.81 | 0.0037 | 0.1343 | 0.0034 | -- | 1.21 | 8,228.57 | -88.79 | -78.95 | -124.14 | -109.86 | 17.86 | -- | -26,121.49 | -243,182.50 | 1.24 | -1.28 | 0.0789 | -- | -- | -- | 8.85 | -- | 48.61 | -- |
CYANOTECH CORP | 23.82m | -5.10m | 5.37m | 77.00 | -- | 0.5026 | -- | 0.2253 | -0.7549 | -0.7549 | 3.56 | 1.53 | 0.8895 | 2.05 | 12.12 | 309,389.60 | -19.04 | -3.46 | -29.60 | -4.46 | 24.72 | 34.54 | -21.41 | -3.58 | 0.3354 | -6.61 | 0.377 | -- | -0.4616 | -5.24 | -53.11 | -- | -6.42 | -- |
Stemtech Corp | 5.37m | -5.11m | 5.59m | 45.00 | -- | -- | -- | 1.04 | -0.0518 | -0.0518 | 0.0529 | -0.0359 | 1.33 | 8.39 | 42.31 | -- | -126.26 | -- | -- | -- | 77.87 | -- | -95.16 | -- | 0.065 | -2.59 | -- | -- | 7.94 | -- | 36.45 | -- | -- | -- |
Hoth Therapeutics Inc | 0.00 | -7.46m | 6.08m | 2.00 | -- | 0.5049 | -- | -- | -1.69 | -1.69 | 0.00 | 1.74 | 0.00 | -- | -- | 0.00 | -67.99 | -157.07 | -76.33 | -177.32 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 31.01 | -- | -- | -- |
Coeptis Therapeutics Holdings Inc | 0.00 | -16.14m | 6.44m | 5.00 | -- | -- | -- | -- | -0.5143 | -0.5143 | 0.00 | -0.0111 | 0.00 | -- | -- | 0.00 | -284.35 | -37.29 | -709.12 | -38.23 | -- | -- | -- | -- | -- | -- | 1.22 | -- | -- | -- | 43.40 | -- | -- | -- |
Bon Natural Life Ltd | 29.52m | 4.60m | 6.55m | 96.00 | 0.3306 | 0.0546 | 1.19 | 0.2219 | 4.99 | 4.99 | 32.10 | 30.23 | 0.7045 | 15.27 | 5.19 | 307,524.60 | 10.86 | 14.04 | 13.69 | 20.68 | 29.94 | 30.00 | 15.42 | 17.62 | 2.41 | 30.54 | 0.0955 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
Biofrontera Inc | 35.24m | -13.51m | 6.98m | 85.00 | -- | 0.5883 | -- | 0.1982 | -5.29 | -5.29 | 12.12 | 2.14 | 1.21 | 1.97 | 7.27 | 414,623.50 | -46.20 | -- | -113.24 | -- | 47.75 | -- | -38.33 | -- | 1.46 | -3.53 | 0.0264 | -- | 18.82 | -- | -3,045.47 | -- | -- | -- |
Aptose Biosciences Inc | 0.00 | -40.29m | 7.25m | 35.00 | -- | -- | -- | -- | -4.45 | -4.45 | 0.00 | -0.1202 | 0.00 | -- | -- | 0.00 | -214.76 | -63.94 | -627.58 | -71.96 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -22.44 | -- | -38.48 | -- |
Guardion Health Sciences Inc | 6.43m | -5.93m | 7.49m | 9.00 | -- | 0.5445 | -- | 1.16 | -4.61 | 4.97 | 5.04 | 10.71 | 0.4467 | 2.74 | 8.20 | 714,121.10 | -41.22 | -77.90 | -45.86 | -86.55 | 44.86 | 42.45 | -92.26 | -176.93 | 16.59 | -2.98 | 0.00 | -- | 10.85 | 67.03 | 101.00 | -- | -58.56 | -- |
Integrated BioPharma, Inc. | 50.32m | 112.00k | 7.52m | 147.00 | 94.66 | 0.391 | 16.98 | 0.1495 | 0.0026 | 0.0026 | 1.62 | 0.6391 | 1.95 | 4.32 | 10.96 | 342,292.50 | 0.4338 | 13.15 | 0.5505 | 19.97 | 7.72 | 11.22 | 0.2226 | 5.87 | 1.08 | -- | 0.0004 | -- | -0.7006 | 0.1357 | 806.25 | -41.77 | 5.96 | -- |
Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 7.81m | 233.00 | 0.0524 | 0.0008 | 2.03 | 0.1104 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
CV Sciences Inc | 15.85m | -2.53m | 8.38m | 42.00 | -- | 3.34 | -- | 0.529 | -0.0157 | -0.0157 | 0.098 | 0.0139 | 1.69 | 1.55 | 25.35 | 377,285.70 | -26.94 | -43.42 | -73.44 | -77.75 | 46.06 | 51.81 | -15.95 | -45.68 | 0.2530 | -- | 0.0114 | -- | -1.24 | -19.80 | 133.96 | -20.87 | -- | -- |